| NCT07010159 | Phase 2/3 Study of KPL-387 in Recurrent Pericarditis | RECRUITING | PHASE2, PHASE3 | 2025-07-31 | 2029-12-31 | 2027-12-31 |
| NCT06531395 | A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease | TERMINATED | PHASE2 | 2024-07-17 | 2025-05-01 | 2025-03-06 |
| NCT05198310 | Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor | COMPLETED | PHASE2 | 2021-12-14 | 2024-05-06 | 2024-02-08 |
| NCT04447469 | Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation | COMPLETED | PHASE2, PHASE3 | 2020-07-28 | 2022-01-14 | 2021-11-12 |
| NCT04497662 | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of KPL-404 in Healthy Subjects | COMPLETED | PHASE1 | 2019-10-22 | 2021-03-02 | 2021-01-21 |
| NCT03737110 | Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis | COMPLETED | PHASE3 | 2019-01-07 | 2022-06-30 | 2020-05-29 |
| NCT03827018 | KPL-301 for Subjects With Giant Cell Arteritis | COMPLETED | PHASE2 | 2018-09-20 | 2020-11-25 | 2020-08-13 |
| NCT03980522 | A Pilot Study of KPL-914 in Recurrent Pericarditis | COMPLETED | PHASE2 | 2018-01-24 | 2019-05-17 | 2019-05-17 |